The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer
暂无分享,去创建一个
Tingting Huang | Yuanqing Li | Zhe Zhang | Yutao Qin | Ting Liu | Xiaoying Zhou | Bo-Yi Li | Wen Wang | Haili Liang | Yaxuan Huang | Yuqi Huang | Rensheng Wang
[1] M. Okpeku,et al. ‘Multi-omics’ data integration: applications in probiotics studies , 2023, NPJ science of food.
[2] J. Mathers. Dietary fibre and health - the story so far. , 2023, The Proceedings of the Nutrition Society.
[3] K. Siedlecka-Kroplewska,et al. Microbiota-derived metabolites in colorectal cancer patients in preoperative period. , 2023, European review for medical and pharmacological sciences.
[4] F. Roviello,et al. Sodium butyrate in both prevention and supportive treatment of colorectal cancer , 2022, Frontiers in Cellular and Infection Microbiology.
[5] Chenyang Zhao,et al. Synergistic effects of sodium butyrate and cisplatin against cervical carcinoma in vitro and in vivo , 2022, Frontiers in Oncology.
[6] M. Kiechle,et al. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. , 2022, The American journal of clinical nutrition.
[7] A. Mondino,et al. Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy , 2022, Journal for ImmunoTherapy of Cancer.
[8] F. Ciardiello,et al. Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab , 2022, International journal of cancer.
[9] Xi-jun Wang,et al. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects , 2022, Frontiers in Oncology.
[10] Jared C Malke,et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response , 2021, Science.
[11] Q. Feng,et al. Soluble Dietary Fiber, One of the Most Important Nutrients for the Gut Microbiota , 2021, Molecules.
[12] K. Obama,et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion , 2021, Nature Communications.
[13] W. Dong,et al. Combining Sodium Butyrate With Cisplatin Increases the Apoptosis of Gastric Cancer In Vivo and In Vitro via the Mitochondrial Apoptosis Pathway , 2021, Frontiers in Pharmacology.
[14] Soojin Lee,et al. Anticancer Effects of Propionic Acid Inducing Cell Death in Cervical Cancer Cells , 2021, Molecules.
[15] M. Shariati,et al. Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis , 2021, Critical reviews in food science and nutrition.
[16] R. Cowles,et al. Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease , 2021, Cells.
[17] T. Gress,et al. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer , 2021, Nature Communications.
[18] M. Szczyrek,et al. Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review , 2021, Nutrients.
[19] Dake Wang,et al. Propionate and Butyrate Produced by Gut Microbiota After Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells In Mice. , 2021, Molecular nutrition & food research.
[20] G. Netto,et al. Gut Microbiota–Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling , 2021, Cancer Research.
[21] Jin Heon Jeon,et al. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel , 2021, Nature Biomedical Engineering.
[22] M. Sohrabi,et al. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] R. Burgos,et al. Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer , 2021, Frontiers in Physiology.
[24] Fenglin Yin,et al. Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy , 2021, Frontiers in Molecular Biosciences.
[25] Glaucia Carielo Lima,et al. Dietary fibers as beneficial microbiota modulators: A proposal classification by prebiotic categories. , 2021, Nutrition.
[26] A. Galanis,et al. Pro-biomics: Omics Technologies To Unravel the Role of Probiotics in Health and Disease. , 2021, Advances in nutrition.
[27] N. Moniri,et al. Short-chain free-fatty acid G protein-coupled receptors in colon cancer. , 2021, Biochemical pharmacology.
[28] Yu-qin Mao,et al. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer , 2021, Theranostics.
[29] E. Martínez-López,et al. Effects of short chain fatty acids on metabolic and inflammatory processes in human health. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[30] H. Foo,et al. Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota , 2021, Microbial Cell Factories.
[31] H. Heidari,et al. Review of short-chain fatty acids effects on the immune system and cancer , 2020 .
[32] K. Whelan,et al. Dietary fibre in gastrointestinal health and disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[33] Yang-zhi Zhao,et al. The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation. , 2020, American journal of cancer research.
[34] S. B. Kim,et al. Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient-derived organoids , 2020, International journal of oncology.
[35] M. Weickert,et al. The Health Benefits of Dietary Fibre , 2020, Nutrients.
[36] David T. W. Tzeng,et al. The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer , 2020, Cancer Immunology Research.
[37] P. Newsholme,et al. Butyrate, generated by gut microbiota, and its therapeutic role in metabolic syndrome. , 2020, Pharmacological research.
[38] Bin Li,et al. Effects of prebiotic dietary fibers and probiotics on human health: With special focus on recent advancement in their encapsulated formulations , 2020, Trends in Food Science & Technology.
[39] D. Mallardo,et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer , 2020, Nature Communications.
[40] Koichi Inoue,et al. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors , 2020, JAMA network open.
[41] Jiaxin Liu,et al. Sodium butyrate inhibits migration and induces AMPK‐mTOR pathway‐dependent autophagy and ROS‐mediated apoptosis via the miR‐139‐5p/Bmi‐1 axis in human bladder cancer cells , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] A. Ichimura,et al. Free Fatty Acid Receptors in Health and Disease. , 2020, Physiological reviews.
[43] D. Zheng,et al. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy , 2019, Nature Biomedical Engineering.
[44] N. Kanayama,et al. Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia , 2019, Nutrition and cancer.
[45] Z. Li,et al. Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids , 2018, Apoptosis.
[46] J. Lapek,et al. Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer , 2018, Cell.
[47] J. Garssen,et al. Pro‐ and anti‐inflammatory effects of short chain fatty acids on immune and endothelial cells , 2018, European journal of pharmacology.
[48] H. M. Kim,et al. Microbial metabolites, short‐chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice , 2018, European journal of immunology.
[49] Kassem M. Makki,et al. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. , 2018, Cell host & microbe.
[50] H. Hao,et al. Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming * , 2018, Molecular & Cellular Proteomics.
[51] Huihua Xia,et al. Impact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire , 2018, Front. Immunol..
[52] M. Tavakoli-Yaraki,et al. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment , 2017, Lipids in Health and Disease.
[53] E. Pistikopoulos,et al. In vitro Studies. , 2017 .
[54] D. Herr,et al. Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells , 2017, PloS one.
[55] Yong Wang,et al. Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients , 2017, Medicine.
[56] Soumen Roy,et al. Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.
[57] Han Liu,et al. Microbiota metabolite short chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43 , 2016, Mucosal Immunology.
[58] Chang H. Kim,et al. Gut Microbial Metabolites Fuel Host Antibody Responses. , 2016, Cell host & microbe.
[59] M. Chandrasekar,et al. Inhibitors of histone deacetylase as antitumor agents: A critical review. , 2016, Bioorganic chemistry.
[60] Nagendra Singh,et al. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. , 2016, Pharmacology & therapeutics.
[61] Renan Corrêa-Oliveira,et al. Regulation of immune cell function by short-chain fatty acids , 2016, Clinical & translational immunology.
[62] T. Preston,et al. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.
[63] Gianni Panagiotou,et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice , 2016, Proceedings of the National Academy of Sciences.
[64] Wendy S. Garrett,et al. Cancer and the microbiota , 2015, Science.
[65] Chang H. Kim,et al. Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation , 2014, Immune network.
[66] V. Godfrey,et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. , 2014, Cancer discovery.
[67] C. Jobin,et al. Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? , 2014, Cell host & microbe.
[68] B. Wilson,et al. Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells , 2014, Cell.
[69] S. Kang,et al. Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway , 2014, Mucosal Immunology.
[70] A. Rudensky,et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.
[71] M. Côrte-Real,et al. Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release , 2013, Cell Death and Disease.
[72] Wei Sun,et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. , 2012, Molecular cell.
[73] O. Feron,et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver , 2012, British Journal of Cancer.
[74] Yinghe Hu,et al. Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. , 2012, Journal of genetics and genomics = Yi chuan xue bao.
[75] D. Faller,et al. Butyrate Histone Deacetylase Inhibitors , 2012, BioResearch open access.
[76] M. Dagli,et al. Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells , 2012, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[77] L. Cosgrove,et al. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate , 2012, British Journal of Nutrition.
[78] Y. Lee,et al. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells , 2011, Oncology reports.
[79] G. Dorta,et al. [Prevention of colorectal cancer]. , 2011, Revue medicale suisse.
[80] X. Coumoul,et al. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex , 2011, International journal of cancer.
[81] D. Nie,et al. G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer , 2011, International journal of cancer.
[82] D. Nie,et al. The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer , 2011, Autophagy.
[83] Z. Liu,et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post‐operative infectious complications in colorectal cancer surgery – a double‐blind study , 2011, Alimentary pharmacology & therapeutics.
[84] J. Lattimer,et al. Effects of Dietary Fiber and Its Components on Metabolic Health , 2010, Nutrients.
[85] Marco Braga,et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. , 2010, World journal of gastroenterology.
[86] E. Barrett,et al. Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. , 2009, The Journal of clinical endocrinology and metabolism.
[87] G. Cresci,et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. , 2009, Cancer research.
[88] S. Calderoni,et al. Cholesterylbutyrate Solid Lipid Nanoparticles as a Butyric Acid Prodrug , 2008, Molecules.
[89] S. Florian,et al. Pectin does not inhibit intestinal carcinogenesis in APC-deficient Min/+ mice. , 2008, Journal of agricultural and food chemistry.
[90] G. Howarth,et al. Short-chain fatty acid modulation of apoptosis in the kato III human gastric carcinoma cell line , 2007, Cancer biology & therapy.
[91] H. Keer,et al. Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer. , 2004, Lung cancer.
[92] R. Kuefer,et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer , 2004, British Journal of Cancer.
[93] J. Davie. Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.
[94] J. Galmiche,et al. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation , 2003, Proceedings of the Nutrition Society.
[95] E. Levy,et al. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway , 2003, Gut.
[96] C. Britten,et al. A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[97] M. Grever,et al. Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[98] M. Nagane,et al. Inhibitory Effects of Sodium Butyrate on Proliferation and Invasiveness of Human Glioma Cells , 2001, Neurosurgery.
[99] D. Nowis,et al. Antitumor activity of tributyrin in murine melanoma model. , 2001, Cancer letters.
[100] R. Hautmann,et al. Tributyrin induces differentiation, growth arrest and apoptosis in androgen‐sensitive and androgen‐resistant human prostate cancer cell lines , 2000, International journal of cancer.
[101] D. Dickson. The story so far… , 2000, Nature.
[102] J. Fujimoto,et al. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo , 1998, International journal of cancer.
[103] S. Meng,et al. p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .
[104] P. Gibson,et al. Short-chain fatty acids promote the migration of colonic epithelial cells in vitro. , 1997, Gastroenterology.
[105] W. Scheppach,et al. Role of short-chain fatty acids in the prevention of colorectal cancer. , 1995, European journal of cancer.
[106] E. Kurschel,et al. Clinical pharmacology of sodium butyrate in patients with acute leukemia. , 1987, European journal of cancer & clinical oncology.
[107] L. R. Jacobs. Effect of dietary fiber on colonic cell proliferation and its relationship to colon carcinogenesis. , 1987, Preventive medicine.
[108] R. Whitehead,et al. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). , 1986, Gut.
[109] D. Dexter,et al. Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells , 1984, The Histochemical Journal.
[110] C. Aring,et al. A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.
[111] Y. Obara,et al. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. , 2007, Cellular signalling.
[112] S. Meng,et al. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[113] C. Young,et al. Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities , 1995, Journal of cellular biochemistry. Supplement.
[114] The health benefits of dietary fibre. , 1991, Nursing RSA = Verpleging RSA.